Cardinal Health (CAH) Sees FY17 EPS at Bottom of Previous Guidance Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Werewolf Therapeutics sells platform assets to EMD Serono for $33M
Cardinal Health (CAH) PT Lowered to $82 at Barclays
April 19, 2017 8:55 AM EDTBarclays lowered its price target on Cardinal Health (NYSE: CAH) to $82.00 (from $88.00) while maintaining a Overweight rating.
... MoreCardinal Health (CAH) to Acquire Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency Businesses from Medtronic (MDT) for $6.1B
April 18, 2017 6:56 AM EDTCardinal Health (NYSE: CAH) today announced that it has entered into a definitive agreement to acquire Medtronic's (NYSE: MDT) Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses for $6.1 billion in cash. The purchase price does not include cash tax benefits of at least $100 million. The acquisition is expected to be financed with a combination of $4.5 billion in new senior unsecured notes and existing cash. The transaction is expected to close in the first quarter of Cardinal Health's fiscal year 2018, subject to customary closing conditions, including regulatory clearances.
The Patient... More
